非小细胞肺癌是临床上最常见的肺癌,约占肺癌总数的80%,患者一旦被确诊多处于晚期,已失去手术时机,临床上多采用常规化疗方案治疗[1]。近年来,我院在采用常规NP化疗方案的基础上,联合应用尿多酸肽治疗晚期非小细胞肺癌取得明显效果。报告如下。1临床资料 Non-small cell lung cancer is the most common clinical lung cancer, accounting for about 80% of the total number of lung cancer patients once diagnosed in more advanced stage, has lost the opportunity to surgery, the clinical use of conventional chemotherapy regimens [1]. In recent years, our hospital in the use of conventional NP chemotherapy based on the combination of uroacitides in patients with advanced non-small cell lung cancer achieved significant results. The report is as follows. 1 clinical data